Cargando…

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis

Detalles Bibliográficos
Autores principales:	Li, Dan-Dan, Zhang, Jia-Wei, Zhang, Rui, Xie, Jie-Hong, Zhang, Kuo, Lin, Gui-Gao, Han, Yan-Xi, Peng, Rong-Xue, Han, Dong-Sheng, Wang, Jie, Yang, Jing, Li, Jin-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104276/ https://www.ncbi.nlm.nih.gov/pubmed/33797470 http://dx.doi.org/10.1097/CM9.0000000000001192

Ejemplares similares

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

The PCNA pseudogenes in the human genome
por: Stoimenov, Ivaylo, et al.
Publicado: (2012)

Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma
por: Yu, Dan-Dan, et al.
Publicado: (2015)

Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR
por: De Biasio, Alfredo, et al.
Publicado: (2012)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Thioredoxin (Trxo1) interacts with proliferating cell nuclear antigen (PCNA) and its overexpression affects the growth of tobacco cell culture
por: Calderón, Aingeru, et al.
Publicado: (2017)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Correction: Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR
Publicado: (2014)

Intrinsic Flexibility of Ubiquitin on Proliferating Cell Nuclear Antigen (PCNA) in Translesion Synthesis
por: Hibbert, Richard G., et al.
Publicado: (2012)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
por: Xiao, Siyu, et al.
Publicado: (2020)

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
por: Klemi, P. J., et al.
Publicado: (1992)

Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
por: Thomas, H., et al.
Publicado: (1995)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: XU, YONGFU, et al.
Publicado: (2015)

The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer
por: Shao, Ming-Tao, et al.
Publicado: (2020)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis
por: Zhang, Jian, et al.
Publicado: (2018)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Jifeng, et al.
Publicado: (2023)

miR-20b overexpression is predictive of poor prognosis in gastric cancer
por: Xue, Tong-min, et al.
Publicado: (2015)

Mismatch Repair proteins are recruited to replicating DNA through interaction with Proliferating Cell Nuclear Antigen (PCNA)
por: Masih, Prerna Jasmine, et al.
Publicado: (2008)

Reduced Stability and Increased Dynamics in the Human Proliferating Cell Nuclear Antigen (PCNA) Relative to the Yeast Homolog
por: De Biasio, Alfredo, et al.
Publicado: (2011)

Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma
por: Lu, Emily Ming-Chieh, et al.
Publicado: (2019)

Nuclear Expression of Pygo2 Correlates with Poorly Differentiated State Involving c-Myc, PCNA and Bcl9 in Myanmar Hepatocellular Carcinoma
por: Htun, Myo Win, et al.
Publicado: (2021)

Proliferating Cell Nuclear Antigen (PCNA) Regulates Primordial Follicle Assembly by Promoting Apoptosis of Oocytes in Fetal and Neonatal Mouse Ovaries
por: Xu, Bo, et al.
Publicado: (2011)

High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Yi-An, et al.
Publicado: (2014)

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
por: Wu, Han, et al.
Publicado: (2016)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis
por: Feng, Hao, et al.
Publicado: (2019)

NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Jing, Ji-sheng, et al.
Publicado: (2018)

Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
por: Guo, Jiang, et al.
Publicado: (2022)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Overexpression of ASPH protein predicts poor outcomes in retroperitoneal liposarcoma patients
por: Xiao, Mengmeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_06mdjjkoknma5a3gfefd822tkn